Kidney Cancer Weekly

July 20, 2026

Videos

Peer-to-Peer Clinical Conversations

Panitumumab plus Nab-Paclitaxel in Renal Medullary Carcinoma and a Prospective Registry - Pavlos Msaouel

Pavlos Msaouel

Pavlos Msaouel presents a prospective multicenter registry study of panitumumab plus nab-paclitaxel in renal medullary carcinoma.

Ultrasensitive ctDNA Detection in Advanced Renal Cell Carcinoma - Juan Ruiz-Bañobre

Juan Ruiz-Bañobre

Juan Ruiz-Bañobre presents an ultrasensitive ctDNA analysis in advanced clear cell RCC, using a tumor-informed whole genome sequencing assay on serial plasma samples from 37 treatment-naive patients collected at baseline, week 6, week 12, and progression.

Beyond the Abstracts

Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry Study - Beyond the Abstract

Agreement of Axial T2-MRI Versus Contrast-Enhanced CT for Solid Renal Mass Active Surveillance - Beyond the Abstract

Conference Coverage

ASCO 2026: PEAK-1: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients with Advanced Clear Cell RCC

AUA 2026: Comparison between IO–IO and IO–TKI Combination Therapies for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus

SES AUA 2026: Assessing the Role of Girentuximab PET/CT in Clinical Decision-Making: Results from a National Survey of Urologic Oncologists

SES AUA 2026: Impact of Cytoreductive Nephrectomy for RCC with Tumor Thrombus: Results from the Intercontinental Collaboration of RCC

Articles

Editor Selected Abstracts and Commentaries

Renal Cancer

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment.

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications.

A Novel 7 Sialylation-Related LncRNA Signature as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

The Role of Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Carcinoma in the Era of Emerging Systemic Therapy: A Retrospective Cohort Study.

Risk Stratification in Renal Cell Carcinoma: A Narrative Review.

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA Study.

Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors.

Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications.

Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187).

First report of safety and outcomes of radiofrequency ablation of renal tumors using a new automated energy delivery-controlled system.

CONNECT WITH US

Questions or Comments? Email us at

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC